Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease. Multiple genetic and environmental factors contribute to the pathogenesis of this disease. Recent genome-wide association studies have added substantially to the number of genes associated with SLE. To replicate some of these susceptibility loci, single-nucleotide polymorphisms reported to be associated to SLE were evaluated in a cohort of 245 well-phenotyped Canadian SLE trios. Our results replicate previously reported associations to alleles of interferon regulatory factor 5 (IRF5), major histocompatibility complex (MHC), tumor necrosis factor (ligand) superfamily member 4 (TNFSF4), Kell blood group complex subunit-related family member 6 (XKR6), B-cell scaffold protein with ankyrin repeats 1 (BANK1), protein tyrosine phosphatase non-receptor type 22 (PTPN22), ubiquitinconjugating enzyme E2L 3 (UBE2L3) and islet cell autoantigen 1 (ICA1). We also identify putative associations to cytotoxic T-lymphocyte-associated protein 4 (CTLA4), a gene associated with several autoimmune disorders, and ERBB3, a locus on 12q13 that was previously reported to be associated with type 1 diabetes. This study confirms the existence of multiple genetic risk factors for SLE, and supports the notion that some risk factors for SLE are shared with other inflammatory disorders.
Introduction
Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease. The hallmark of SLE is the presence of pathogenic autoantibodies to nuclear and cell-surface antigens. Multiple tissues, including skin, joints, blood cells, central nervous system and kidneys can be affected, and presenting symptoms may range from rashes and anemia to arthritis, psychosis and nephritis. The underlying cause of SLE seems to be dysregulation of both the innate and adaptive immune systems, coupled to defective clearance of apoptotic debris. The inefficient elimination of apoptotic material and an overactive immune response are thought to lead to the production of high-affinity autoantibodies that are responsible for the resulting organ damage. 1, 2 The prevalence of SLE in Americans of northern European ancestry is estimated to be 10-40 per 100 000, whereas African and Hispanic Americans have a two-to fivefold higher risk. 3 Disease is far more common in women compared to men and over 85% of patients are female. 4 The etiology of SLE is complex, involving genetic susceptibility and environmental triggers. The concordance rate in monozygotic twins is 25% compared with 2% for dizygotic pairs, indicating an important genetic contribution to SLE, 5 as well as the influence of environmental factors, such as exposure to infectious agents and ultraviolet light.
SLE is a complex genetic disease and for the vast majority of patients variation at multiple genetic loci contributes to risk. Only in rare cases, such as homozygous deficiency of components in the classic complement pathway 6 and mutations in the exonuclease TREX1, 7 are single gene defects major contributors to disease. Early studies using candidate gene and linkage approaches identified variation in several loci, including the major histocompatibility complex (MHC) region, tumor necrosis factor (ligand) superfamily member 4 (TNFSF4), PDCD1, interferon regulatory factor 5 (IRF5), protein tyrosine phosphatase, non-receptor type 22 (PTPN22), signal transducer and activator of transcription 4 (STAT4), FCGR2A and FCGR3B, that are associated with increased risk of SLE. 8 With the advent of technology to perform genome-wide association (GWA) studies the number of SLE susceptibility regions has increased dramatically. 9, 10 Within the last 2 years, six groups have published GWA studies that have confirmed and expanded the list of SLE risk loci to over 25. [11] [12] [13] [14] [15] [16] The objective of the work presented in this paper was to replicate previously reported risk alleles for SLE in a well-characterized cohort of SLE trios using the transmission disequilibrium test, which is robust against population stratification.
17 Also, as GWA studies for an increasing number of inflammatory diseases are reported, it is becoming apparent that there are shared genetic susceptibly loci. 18 ,19 Thus, we tested for the possible role in SLE of risk alleles recently identified in other complex immune disorders, including IRGM, interleukin-23 receptor (IL23R), ATG16 autophagyrelated 16-like 1 (ATG16L1), IBD5, NOD2 and prostaglandin E receptor 4 (PTGER4) in Crohn's disease, TRAF1-C5 in rheumatoid arthritis, and interleukin-2 receptor A (IL2RA), interleukin-7 receptor (IL7R), PTPN2, cytotoxic T-lymphocyte-associated protein 4 (CTLA4) and ERBB3 in type 1 diabetes (T1D). Our results strongly replicate previously reported associations to alleles of B-cell scaffold protein with ankyrin repeats 1 (BANK1), islet cell autoantigen 1 (ICA1), MHC, IRF5, PTPN22, TNFSF4, ubiquitin-conjugating enzyme E2L 3 (UBE2L3) and Kell blood group complex subunit-related family, member 6 (XKR6). We also identify putative association to CTLA4, and ERBB3 genes; risk factors previously associated with T1D.
Results and discussion
In an effort to replicate published genetic risk factors for SLE, we have performed an association study in a wellcharacterized cohort of SLE trios collected in Canada. The clinical and demographics of this cohort are summarized in Table 1 . Single-nucleotide polymorphisms (SNPs) from 15 SLE risk loci were tested. Moreover, in four genomic regions, where published reports suggested the presence of multiple independent associated alleles, we typed multiple SNPs to determine if independent variants contributed to SLE risk. In addition to the SLE loci, 18 candidate genes from other immune disorders were tested. Thus, a combined total of 74 SNPs for 33 loci were genotyped in 245 Canadian trios. Table 2 lists these loci and the number of SNPs tested for each region. An additional 10 SNPs, in four loci (STAT4, B lymphoid tyrosine kinase (BLK), integrin-a M (ITGAM)-integrin-a X (ITGAX) and tumor necrosis-a factorinduced protein 3 (TNFAIP3)) that were previously typed for a subset of the trios, 12 are also listed in Table 2 and are included in this study to provide a more complete picture of the genetic variation associated in this SLE cohort.
Association with SNPs previously reported to be SLE risk loci We observed an association to SLE susceptibility for 23 SNPs at 12 different SLE loci (Po0.05; Table 3 ; results for all SNPs are listed in Supplementary Table 1 ). Eight loci (IRF5, MHC, STAT4, BLK-C8orf13, TNFSF4, TNFAIP3, XKR6 and ITGAM-ITGAX) replicated with a P-value o0.01 and in general these are loci with higher odds ratio (41.4 ). An additional four loci (BANK1, PTPN22, UBE2L3 and ICA1) replicated with P-values between 0.01 and 0.05. These results are consistent with the sample size and the modest risk that is conferred by most loci (see Figure 1 ) and illustrate the power of the study, given our sample size of 245 trios. The different curves shown in Figure 1 indicate the power to detect association as a function of odds ratio at different minor allele frequencies, ranging from 0.04 to 0.4.
To examine whether any of the associated genetic variants influence the phenotypic expression of the For this study, we used 245 case-parent trios from this cohort. The majority of the probands were self-reported as Caucasian. All but one case had four or more of the revised ACR classification criteria for systemic lupus erythematosus and, as expected, cases were mostly female (90%). Informed consent was obtained from all the participants and the study was approved by the ethics review committee of the participating hospitals and clinics. Pertinent clinical and laboratory information was registered, and peripheral blood was collected from the subjects for DNA isolation.
Targeted association study in SLE ML Budarf et al disease, we performed a genotype-phenotype analysis. Specifically, given its prevalence, we focused on renal involvement in SLE. We first tested the variants for association in each phenotypic subgroup (Table 3) .
We then evaluated whether there was a significant difference in the transmission of the associated allele in patients with renal versus non-renal involvement or whether the observed differences could be because Multiple SNPs were tested to examine both genes at this locus. In all, 74 SNPs, from 33 genes/loci, were chosen based on review of the literature of genetic association to SLE or other autoimmune diseases. An additional 10 SNPs from 4 loci (STAT4, BLK, ITGAM-ITGAX and TNFAIP3) previously reported for a subset of the trios, are also listed in the table. SNP genotyping was performed on a Sequenom MassArray iPLEX single-base extension platform. Genotyping assays were designed using the MassARRAY Assay Design software (version 3.0, Sequenom Inc, San Diego, CA, USA). All primers were purchased from IDT (Coralville, IA, USA).
Targeted association study in SLE ML Budarf et al of chance alone. This latter analysis demonstrates that although there seem to be differences between the phenotypic subgroups, none were statistically significant ( Table 3) .
The majority of genes that we found to be associated with a genetic risk of SLE are involved in the innate and adaptive immune response. 9 ITGAM, TNFSF4 and MHC are known to participate in antigen processing, presentation and recognition. IRF5, STAT4, PTPN22 and CTLA4 have important functions in T cell activation/ regulation, and BLK and BANK1 are involved in the early steps of B cell receptor signaling. The ubiquitinediting protease, TNFAIP3, has a central role in downregulating nuclear factor-kB, and thus controlling proinflammatory signals of the innate immune response, 20 and UBE2L3, the E2 ubiquitin-conjugating enzyme, has been implicated in regulation of the proinflammatory Toll-like receptor (TLR) response. 21 Lastly, ERBB3 is a member of the epidermal growth factor receptor family and is involved in cell proliferation, 22 whereas the function of the remaining two loci, ICA1 and XKR6 are unknown. Abbreviations: BANK1, B-cell scaffold protein with ankyrin repeats 1; BLK, B lymphoid tyrosine kinase; CTLA4, cytotoxic T-lymphocyteassociated protein 4; GWA, genome-wide association; ICA1, islet cell autoantigen 1; IRF5, interferon regulatory factor 5; MHC, major histocompatibility complex; OR, odds ratio; PTPN22, protein tyrosine phosphatase non-receptor type 22; SCUBE1, signal peptide, CUB domain, epidermal growth factor-like 1; SLE, systemic lupus erythematosus; SNP, single-nucleotide polymorphism; STAT4, signal transducer and activator of transcription 4; TNFAIP3; tumor necrosis factor-a-induced protein 3; UBE2L3, ubiquitin-conjugating enzyme E2 L 3; UTR, untranslated region; XKR6, XK, Kell blood group complex subunit-related family member 6. a P-values are two-tailed for candidate SNPs from other immune related diseases, and one-tailed for previously reported SLE associations.
b SNPs for which association was already reported in this cohort Quality control and data analysis were performed using PLINK (v0.99 s, http://pngu.mgh.harvard.edu/purcell/plink/) and Haploview Software. 54 In all, 268 family trios typed for 93 SNPs were initially included in the study. Incomplete families, individuals with low genotyping rate (o90%), along with their families, and families showing high Mendel errors rates (460 Mendel errors/family) were excluded. SNPs with low genotyping rate (o90%), significantly out of Hardy-Weinberg equilibrium (Po0.001) or showing high Mendel errors (47/SNP) were also excluded. After quality control, the dataset showed an overall genotyping rate of 99.4% and consisted of 245 trios and 74 SNPs. Association of individual SNPs to SLE was tested with the transmission disequilibrium test. 17 SNPs showing significant association at a significance level of Po0.05 are listed in this table. The complete list of SNPs can be found in Supplementary Table 1 . An additional four SNPs from four loci (STAT4, BLK, ITGAM-ITGAX and TNFAIP3,) previously reported for a subset of the trios and showing significant association are also listed in the table. For each SNP of interest, we performed a genotype-phenotype analysis for renal involvement in SLE; for this, we independently tested the association of each SNP in patients with renal involvement and without (P-renal and P-nonrenal, respectively). To evaluate the significance of our observations, we tested for difference in effect size between renal and nonrenal groups by comparison of OR. Briefly, we summarized transmitted and untransmitted counts from both groups as a 2 Â 2 contingency table, on which a w 2 -test of independence was performed; no significant difference in subphenotypic effect was found, even at a nominal level (P-subphenotype effect o0.05).
Targeted association study in SLE ML Budarf et al
Testing for multiple independent association signals within a single gene locus In some of the previously reported SLE loci a multiplicity of association signals have been identified. For these regions we have typed multiple genetic variants to test for independent effects within each individual locus (see Supplementary Table 2 for summary of conditional analysis). The MHC region has been shown to contain the strongest association signals in recent GWA studies of SLE. [11] [12] [13] Previous studies using simple sequence length polymorphism typing in European populations have suggested a potential role for the human leukocyte antigen (HLA)-DRB1Ã08:01, HLA-DRB1Ã03:01 and HLA-DRB1Ã15:01 alleles in SLE. 23, 24 More recently, a study from the International MHC and Autoimmunity Genetics Network (IMAGEN) consortium, using high density SNP typing across the MHC, combined with imputation of HLA alleles, has identified HLA-DRB1Ã03:01 and HLA-DRB1Ã15:01 as the two major, independent, association signals in this region. 25 This study also suggested that two non-HLA variants highly correlated to the HLA-DRB1Ã03:01 and HLA-DRB1Ã15:01 alleles (rs1269852 located between TNXB and ATF6B(CREBL1), and rs3135391 located within HLA-DRA, respectively) could explain the observed association. A study by Fernando et al. 26 identified an additional signal, potentially independent from HLA-DRB1Ã03:01 and HLA-DRB1Ã15:01. The associated SNP, rs419788, is located within an intron of the class III gene SKIV2L.
26
To replicate these observations, we tested these three potentially independent signals (rs1269852, rs3135391 and rs419788), along with two SNPs selected to tag the HLA-DRB1Ã03:01 and HLA-DRB1Ã15:01 alleles (rs2040410 and rs3135388, respectively) 27 for association to SLE in our cohort. Our results show significant association for all five SNPs tested ( Table 3) . As expected from previous reports, rs1269852 shows the strongest association signal (P ¼ 3.11 Â 10
À4
) in the MHC region. A conditional logistic regression analysis on this top signal (Supplementary Table 2) indicates that the second strongest association signal in the region, the HLA-DRB1Ã03:01 tag (rs2040410, P ¼ 0.0023, conditional P ¼ 0.16), is not independent from rs1269852. This conditional analysis also reveals that both rs3135391 (P ¼ 0.02, conditional P ¼ 0.013) and the HLA-DRB1Ã15:01 tag (rs3135388, P ¼ 0.02, conditional P ¼ 0.017) show significant signal independent from rs1269852. A conditional analysis on the independent secondary signal rs3135391 reveals that the HLA-DRB1Ã15:01 tag SNP (rs3135388) is not independent from rs3135391. Finally, the third reported independent signal located in the class III region, rs419788, although significantly associated to SLE (P ¼ 0.010) was not found to be independent from the rs3135391/HLA-DRB1Ã15:01 signal in our cohort (conditional P ¼ 0.07). Our results confirm the existence of at least two independent signals in the MHC region for SLE.
The genomic region containing the IRF5 gene has also been reported to have multiple, independent, association signals in Caucasian populations. 28, 29 We therefore tested 22 IRF5 SNPs spanning 80 kb and found that 6 have significant association (Table 3) . Conditional analysis (Supplementary Table 2 ) indicates that our top signal is for rs729302 with significant secondary signal to a set of three SNPs (rs2070197, rs10488631, rs12539741: conditional P ¼ 0.032) that are reported to be highly correlated (pairwise r 2
40.95).
28 This secondary signal was reported to demonstrate the strongest association to SLE in a study of 555 US and UK families. 28 Multiple functional variants have been reported for IRF5, including, two functional variants, a splice donor site for exon 1B/ rs2004640 and a CGGGG indel upstream of the first exon, that are correlated with rs729302. 28, 29 Thus, we can confirm the association to rs729302, and rs2070197, rs10488631, rs12539741 but do not have the power to distinguish the contribution of additional variants that have been reported for IRF5.
Multiple studies have reported association to different genes within a B700 kb region of 8p23.1. [11] [12] [13] This region contains several candidate genes, including XKR6, BLK, FAM167A/C8orf13 and C8orf12, in significant linkage disequilibrium (LD), making it difficult to determine whether the different reports are detecting the same association signal. We found significant association to both the BLK (rs2618476) and XKR6 (rs6985109) genes (Table 3) . Although these two SNPS are separated by 620 kb, there is relatively strong correlation between them (r 2 ¼ 0.39), allowing the possibility that they may represent the same signal. A reciprocal conditional analysis (Supplementary Table 2 ) of these two SNPs indicates that they might not represent independent signals. This and previous studies have not distinguished between causal variant(s) and markers in LD and thus, the causal gene(s) remains to be determined. Figure 1 The power to detect signal in a one-tailed transmission disequilibrium test at a significance level of 0.05, given our sample size of 245 trios. The upper curve is the power for a minor allele frequency of 0.4, while the middle and lower curve are for minor allele frequency of 0.1 and 0.04, respectively. Loci have been added to the plot to illustrate the power of our study for some of the variants genotyped in the replication. We calculate that to reach a power of 80% to detect all SNPs at significance level of 0.05, we would need to increase the number of trios almost fourfold to 950. For each gene the most associated SNP, reported in publications and in the set we genotyped, was taken to represent the maximum expected power of our study. We used previously published odds ratio (OR) and the minor allele frequency from our sample to estimate power, using Hardy-Weinberg equilibrium to estimate expected heterozygosity among parents. When more than one odds ratio was available for a gene, we used a median value. The genes with the most significant P-values (see Table 3 and Supplementary  Table 1 ) are represented with bigger points, while non-replicated genes are in white.
Three SNPs (rs1234314, rs2205960 and rs7514229) in the TNFSF4 gene were selected for replication, based on the haplotype structure determined by Cunninghame Graham et al. 30 An additional SNP (rs10798269), mapping 133 kb upstream of TNFSF4 in a gene desert, was shown to be significant at Po10 À6 in a GWA study 13 and was also included for replication. Of the three TNFSF4 SNPs, only rs2205960, which maps to the upstream region (15 kb from the start of transcription), shows significant association (P ¼ 0.0056). The far upstream SNP, rs10798269, has very modest association with our trios (P ¼ 0.047). Reciprocal conditional analysis (Supplementary Table 2 ) of the two associated SNPs (rs2205960 and rs10798269) suggest that they are not independent (for rs10798269 conditional P ¼ 0.074).
Lastly, an association of BANK1 with SLE was detected in a GWA scan.
14 Multiple SNPs demonstrate association, including rs10516487, which results in a non-synonymous substitution of arginine to histidine at amino acid 61 of the BANK1 protein. However, it has not been possible to determine the independent contributions of the SNPs because they are in strong LD.
14 Three SNPs, rs10516487, rs10516482 and rs10512483, were selected for replication in the Canadian trios; rs10516487 (P ¼ 0.011) and rs10516483 (P ¼ 0.022) showed significant association (Table 3 ). rs10516487 and rs10516483 are moderately correlated with an r 2 ¼ 0.50, and separated by 29 kb. Reciprocal conditional analysis (Supplementary Table 2 ) of these two associated SNPs suggests that they are not independent. Although LD prevents us and others from ascertaining the causative variant, the Arg 61 His is an excellent candidate.
Association with SNPs previously reported to be risk loci for other autoimmune diseases Of the 18 candidate genes tested, we detected modest evidence of association to CTLA4 and ERBB3 (Table 3) . Although of nominal significance, the finding of CTLA4 with our SLE cohort is of interest because variation in the CTLA4 gene has been associated with several autoimmune diseases, including Graves disease 31 autoimmune hypothyroidism 31 and T1D. 32, 33 Candidate gene studies of CTLA4 for SLE have been contradictory with some studies reporting an association and others finding none. The most consistent correlation with SLE has been variation in the 3 0 untranslated region and the downstream intergenic region, the same region that encompasses rs3087243. [34] [35] [36] However, the region of chromosome 2q33.2 that contains CTLA4 has not been reported in any of the SLE GWA studies.
Nominal association was also detected with variation in the ERBB3 locus (Table 3) . ERBB3 was selected as a candidate gene for the SLE study because the gene showed strong evidence of association with T1D in two GWA studies. 32, 37 However, there is extensive LD in this segment of 12q13 and multiple genes are within the 450 kb critical region that contains ERBB3. 32 The possible association with SLE will require follow-up studies with additional SNPs.
Conclusion
Independent replication is an important step in the process of confirming the genetic risk loci of complex diseases because the individual contribution of most loci to the pathogenesis is small, making validation statistically challenging. We have presented evidence for the replication of 12 of 19 SLE loci tested and provide novel evidence that two loci, previously associated with T1D, are associated with SLE, providing further support for shared risk factors across multiple inflammatory diseases.
